Lee Han-Soo writing for Korea Biomedical Review notes that Genexine and NeoImmune Tech have received approval from the U.S. Food and Drug Administration (FDA) to conduct clinical trials of combination treatment of HyLeukin-7, an immunotherapeutic drug candidate and...